E. Thiel

University Hospital of Zurich — Switzerland

Medicine · Health Sciences

33h-index3.6kcitations206works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(42), Acute Lymphoblastic Leukemia research(37), Chronic Lymphocytic Leukemia Research(33), Chronic Myeloid Leukemia Treatments(21), Lymphoma Diagnosis and Treatment(20)

Publications205 total

Gibt es Fortschritte in der Therapie niedrigmaligner Non-Hodgkin-Lymphome?
2015
Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma
Neuro-Oncology·2015· 53 citedOpen Access
Management of primary intraocular lymphoma (PIOL): Results from the prospective German PIOL registry (PIOL-R).
Journal of Clinical Oncology·2014· 1 cited
Molecular characteristics of FLT3 mut ETP-ALL versus FLT3 wt ETP-ALL patients.
2013
Erratum
Onkologie·2012Open Access
Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations
Blood Cancer Journal·2012· 129 citedOpen Access
Chronic Graft versus Host Disease but not the Intensity of Conditioning has Impact on Survival after Allogeneic Hematopoietic Stem Cell Transplantation for Advanced Hematological Diseases
Onkologie·2012· 3 citedOpen Access
Vol. 35, Issue 9, September 2012 / Band 35, Heft 9, September 2012
Onkologie·2012Open Access
Imprint
Onkologie·2012Open Access
PharmaNews
Onkologie·2012Open Access
Editorial Board
Onkologie·2012Open Access
Meetings and Conferences · Tagungen und Kongresse
Onkologie·2012Open Access
Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia
Blood Cancer Journal·2011· 74 citedOpen Access
Systemic and intrathecal chemotherapy followed by high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: A potentially curative approach?
Journal of Clinical Oncology·2011· 3 cited
Prognostic factors for chemotherapy-related toxicity in primary central nervous system lymphoma (PCNSL) treated with high-dose methotrexate (HDMTX) with or without ifosfamide: Results from a German phase III trial (G-PCNSL-SG-1).
Journal of Clinical Oncology·2011· 6 cited
Treatment of relapsed acute lymphoblastic leukemia (ALL): Improved results in GMALL studies but optimisation is an ongoing challenge
2011
Prognostic Relevance of Circulating Tumor Cells in Metastatic Uveal Melanoma
Oncology·2011· 34 cited
Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.
PubMed·2011· 6 cited
Systemic Immune Tuning in Renal Cell Carcinoma
Journal of Immunotherapy·2010· 16 cited
“Wilms Tumor Protein 1” (WT1) Peptide Vaccination-induced Complete Remission in a Patient With Acute Myeloid Leukemia Is Accompanied by the Emergence of a Predominant T-cell Clone Both in Blood and Bone Marrow
Journal of Immunotherapy·2010· 29 cited
page 1 of 11Next →

Frequent Co-authors

Stefan Schwartz(13), Ulrich Keilholz(11), Alexander Schmittel(8), Thomas Burmeister(8), Nicola Gökbuget(7), D. Hoelzer(6), Thomas Büchner(5), Harald Rieder(5), Torsten Haferlach(5), W. Gaßmann(5), Christa Fonatsch(5), Wolfgang Ludwig(4), Dieter Hoelzer(4), Georg Maschmeyer(4), Sandra Heesch(3), Cornelia Schlee(3), Claudia D. Baldus(3), R. Schuster(3), Andrea Stroux(3), Nikolaos E. Bechrakis(3)